Literature DB >> 27453915

Adoptive Transfer of Memory B Cells.

Griselda Zuccarino-Catania1, Mark Shlomchik2.   

Abstract

The adoptive transfer of antigen-specific B cells into mice that cannot recognize that specific antigen has two main advantages. The first is determining exactly when the B cells were transferred and exposed to antigen. The second is that all B cells that can bind that antigen are the ones that were transferred; no new antigen-specific B cells will emerge from the bone marrow. Thus all B cells that were exposed to the antigen and still alive after at least 4 weeks (8 weeks or more is ideal), are memory B cells. Splenic B cells from B1-8 mice were prepared with an EasySep Mouse B Cell Enrichment Kit according to the manufacturer's protocol. Single-cell suspensions were transferred intravenously into tail veins of recipient mice. Approximately 1 million NP+ B cells were transferred per mouse. Approximately 12-24 h after transfer, mice were immunized intra-peritoneally with 50 µg of NP-CGG precipitated in alum.

Entities:  

Year:  2015        PMID: 27453915      PMCID: PMC4957582          DOI: 10.21769/bioprotoc.1563

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  8 in total

1.  Cutting edge: Hierarchy of maturity of murine memory B cell subsets.

Authors:  Mary M Tomayko; Natalie C Steinel; Shannon M Anderson; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

2.  B cell development under the condition of allelic inclusion.

Authors:  E Sonoda; Y Pewzner-Jung; S Schwers; S Taki; S Jung; D Eilat; K Rajewsky
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

3.  A rheumatoid factor transgenic mouse model of autoantibody regulation.

Authors:  M J Shlomchik; D Zharhary; T Saunders; S A Camper; M G Weigert
Journal:  Int Immunol       Date:  1993-10       Impact factor: 4.823

4.  Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses.

Authors:  Rebecca A Sweet; Jaime L Cullen; Mark J Shlomchik
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

5.  A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease.

Authors:  L G Hannum; D Ni; A M Haberman; M G Weigert; M J Shlomchik
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

6.  Light chain replacement: a new model for antibody gene rearrangement.

Authors:  E L Prak; M Weigert
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

7.  B cell development in mice that lack one or both immunoglobulin kappa light chain genes.

Authors:  J Chen; M Trounstine; C Kurahara; F Young; C C Kuo; Y Xu; J F Loring; F W Alt; D Huszar
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

8.  CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype.

Authors:  Griselda V Zuccarino-Catania; Saheli Sadanand; Florian J Weisel; Mary M Tomayko; Hailong Meng; Steven H Kleinstein; Kim L Good-Jacobson; Mark J Shlomchik
Journal:  Nat Immunol       Date:  2014-06-01       Impact factor: 25.606

  8 in total
  3 in total

1.  T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.

Authors:  Sonia George; Trevor Tyson; Nolwen L Rey; Rachael Sheridan; Wouter Peelaerts; Katelyn Becker; Emily Schulz; Lindsay Meyerdirk; Amanda R Burmeister; Christian U von Linstow; Jennifer A Steiner; Martha L Escobar Galvis; Jiyan Ma; J Andrew Pospisilik; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

2.  Protection of Quiescence and Longevity of IgG Memory B Cells by Mitochondrial Autophagy.

Authors:  Srikanth Kodali; Min Li; Marietta M Budai; Min Chen; Jin Wang
Journal:  J Immunol       Date:  2022-01-31       Impact factor: 5.422

3.  A Posttranscriptional Pathway of CD40 Ligand mRNA Stability Is Required for the Development of an Optimal Humoral Immune Response.

Authors:  Bitha Narayanan; Diego Prado de Maio; James La Porta; Yekaterina Voskoboynik; Usha Ganapathi; Ping Xie; Lori R Covey
Journal:  J Immunol       Date:  2021-05-24       Impact factor: 5.426

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.